PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Metsä Board Oyj (METSA.HE)
5.580.04 (-0.71%)
5.38 - 5.60
4.95 - 8.28
2.3K / 2.4K (Avg.)
-279.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-5.76%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
127.85%
Positive gross profit growth while HUH1V.HE is negative. John Neff would see a clear operational edge over the competitor.
-4.11%
Negative EBIT growth while HUH1V.HE is at 5.52%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-4.11%
Negative operating income growth while HUH1V.HE is at 5.52%. Joel Greenblatt would press for urgent turnaround measures.
-9.81%
Negative net income growth while HUH1V.HE stands at 5.33%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-11.50%
Negative EPS growth while HUH1V.HE is at 5.26%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-11.50%
Negative diluted EPS growth while HUH1V.HE is at 5.26%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
1.92%
Share count expansion well above HUH1V.HE's 0.02%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
1.92%
Slight or no buyback while HUH1V.HE is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
-133.84%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-273.86%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-32.13%
Negative 10Y revenue/share CAGR while HUH1V.HE stands at 28.50%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-34.81%
Negative 5Y CAGR while HUH1V.HE stands at 43.83%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-4.61%
Negative 3Y CAGR while HUH1V.HE stands at 17.08%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-209.24%
Negative 10Y OCF/share CAGR while HUH1V.HE stands at 12.47%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-165.31%
Negative 5Y OCF/share CAGR while HUH1V.HE is at 371.77%. Joel Greenblatt would question the firm’s operational model or cost structure.
-159.11%
Negative 3Y OCF/share CAGR while HUH1V.HE stands at 830.85%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
120.17%
Net income/share CAGR 1.25-1.5x HUH1V.HE's 91.35%. Bruce Berkowitz might see more effective use of capital or consistently better margins over time.
-12.50%
Negative 5Y net income/share CAGR while HUH1V.HE is 109.06%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
250.00%
3Y net income/share CAGR above 1.5x HUH1V.HE's 68.36%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
-1.01%
Negative 5Y equity/share growth while HUH1V.HE is at 26.16%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
38.46%
3Y equity/share CAGR above 1.5x HUH1V.HE's 22.52%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative near-term dividend growth while HUH1V.HE invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
42.10%
AR growth well above HUH1V.HE's 18.11%. Michael Burry fears inflated revenue or higher default risk in the near future.
9.75%
Inventory growth well above HUH1V.HE's 3.63%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
0.51%
Asset growth well under 50% of HUH1V.HE's 3.22%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
-5.98%
We have a declining book value while HUH1V.HE shows 1.36%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
5.85%
Debt shrinking faster vs. HUH1V.HE's 11.85%. David Dodd sees a safer balance sheet if it doesn't impair future growth.
-100.00%
Our R&D shrinks while HUH1V.HE invests at 7.50%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-3.18%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.